<DOC>
	<DOCNO>NCT00711074</DOCNO>
	<brief_summary>The purpose study determine body break excrete investigational drug , AZD5672 .</brief_summary>
	<brief_title>Mass Balance Metabolic Profiling 14CAZD5672 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>N- ( 1- ( 3- ( 3,5-difluorophenyl ) -3- ( 4-methanesulfonylphenyl ) propyl ) piperidin-4-yl ) -N-ethyl-2- ( 4-methanesulfonylphenyl ) acetamide</mesh_term>
	<criteria>Body Mass index ( BMI ) 1830 kg/m2 , inclusive . Clinically normal finding physical examination , ECG , vital sign , clinical chemistry , haematology &amp; urinalysis , judge investigator Healthy volunteer expose radiation level background ( eg Xray examination ) &gt; 5 mSv last year , &gt; 10 mSv last 5 year cumulative total &gt; 1 mSv per year life Clinically significant illness within 2 week prior dose , judge investigator Use prescribed medication ( include St. John 's Wort ) 3 week prior dose use counter drug ( include herbal , vitamin mineral ) 1 week prior dose ( occasional paracetamol use )</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>mass balance</keyword>
	<keyword>radiolabel</keyword>
	<keyword>AZD5672</keyword>
</DOC>